These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3088662)

  • 1. The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.
    Parrott AC
    Psychopharmacology (Berl); 1986; 89(3):347-54. PubMed ID: 3088662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.
    Parrott AC; Wesnes K
    Psychopharmacology (Berl); 1987; 92(4):513-9. PubMed ID: 3114803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral scopolamine on human stimulus evaluation.
    Callaway E; Halliday R; Naylor H; Schechter G
    Psychopharmacology (Berl); 1985; 85(2):133-8. PubMed ID: 3925478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermally applied scopolamine does not impair psychomotor performance.
    Gleiter CH; Antonin KH; Bieck PR
    Psychopharmacology (Berl); 1984; 83(4):397-8. PubMed ID: 6436873
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.
    Flicker C; Serby M; Ferris SH
    Psychopharmacology (Berl); 1990; 100(2):243-50. PubMed ID: 2305013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
    Parrott AC
    Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal scopolamine: effects of single and repeated patches upon psychological task performance.
    Parrott AC
    Neuropsychobiology; 1987; 17(1-2):53-9. PubMed ID: 3627392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.
    Nuotto E
    Eur J Clin Pharmacol; 1983; 24(5):603-9. PubMed ID: 6873137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of melatonin on human mood and performance.
    Lieberman HR; Waldhauser F; Garfield G; Lynch HJ; Wurtman RJ
    Brain Res; 1984 Dec; 323(2):201-7. PubMed ID: 6525511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central effects of scopolamine in man.
    Safer DJ; Allen RP
    Biol Psychiatry; 1971; 3(4):347-55. PubMed ID: 4950489
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of transdermal scopolamine upon psychological test performance at sea.
    Parrott AC; Jones R
    Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the information processing and mood effects of a transdermal nicotine patch.
    Warburton DM; Mancuso G
    Psychopharmacology (Berl); 1998 Feb; 135(3):305-10. PubMed ID: 9498735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to scopolamine in the elderly.
    Flicker C; Ferris SH; Serby M
    Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of alcohol and transdermally administered scopolamine.
    Gleiter CH; Antonin KH; Schoenleber W; Bieck PR
    J Clin Pharmacol; 1988 Dec; 28(12):1123-7. PubMed ID: 3243930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal scopolamine: human performance and side effects.
    Gordon C; Binah O; Attias J; Rolnick A
    Aviat Space Environ Med; 1986 Mar; 57(3):236-40. PubMed ID: 3964152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight transdermal scopolamine patch administration has no clear effect on cognition and emotional processing in healthy volunteers.
    Bukala BR; Browning M; Cowen PJ; Harmer CJ; Murphy SE
    J Psychopharmacol; 2019 Feb; 33(2):255-257. PubMed ID: 30526264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of scopolamine on working memory in healthy young volunteers.
    Rusted JM; Warburton DM
    Psychopharmacology (Berl); 1988; 96(2):145-52. PubMed ID: 3148139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.